Lovisa (ASX: LOV) H1 FY 2023 Results: Profit Soars Over 30%

The H1 FY 2023 Lovisa (ASX: LOV) showed strong profit and revenue growth, but shareholders do take on some risk.

News - Page 2 of 414 - The Sentiment

GenusPlus (ASX: GNP) - The Sentiment

Lovisa (ASX: LOV) FY 2022 Results Shines Ever So Brightly

News - Page 24 of 413 - The Sentiment

Akari Therapeutics Reports First Half 2023 Financial Results and Highlights - Akari Therapeutics

Ethical Equities Investing Archives - Page 5 of 23 - A Rich Life

Lovisa (LOV) Stock Price, News & Analysis

Alpha HPA (ASX: A4N) - The Sentiment

Alpha HPA (ASX: A4N) - The Sentiment

Bioxyne (ASX: BXN) - The Sentiment

Ethical Equities Investing Archives - Page 5 of 23 - A Rich Life

Lovisa Holdings' (ASX:LOV) five-year earnings growth trails the 24% YoY shareholder returns